Patents Assigned to Merck Patents GmbH
  • Patent number: 9390864
    Abstract: The present invention relates to the use of at least one imidazol derivative of formula I or 1-(3,3,4,4,4-pentafluorobutyl)-1H-imidazole, 1-(3,3,4,4,4-pentafluorobutyl)-1,2,3-triazole or 1-(2?-thioethyl)ethylimidazole as additive in dye-sensitized solar cells and to special electrolyte formulations and a dye-sensitized solar cell comprising at least one compound of formula I or 1-(3,3,4,4,4-pentafluorobutyl)-1H-imidazole, 1-(3,3,4,4,4-pentafluorobutyl)-1,2,3-triazole or 1-(2?-thioethyl)ethylimidazole.
    Type: Grant
    Filed: July 23, 2015
    Date of Patent: July 12, 2016
    Assignee: MERCK PATENT GMBH
    Inventors: Kentaro Kawata, Tomohisa Goto, Hiroki Yoshizaki
  • Publication number: 20160194380
    Abstract: The present invention pertains to highly potent Matriptase inhibitors derived from the miniprotein McotI-II.
    Type: Application
    Filed: April 8, 2014
    Publication date: July 7, 2016
    Applicant: Merck Patent GmbH
    Inventors: Michael TOMASZOWSKY, Niklas WEBER, Bernhard GLOTZBACH, Harald KOLMAR, Bjoern HOCK
  • Patent number: 9382253
    Abstract: The present invention relates to metal complexes which contain polymerizable groups and to the polymers obtained using these metal complexes and to electronic devices, in particular organic electroluminescent devices, comprising these polymers. The metal complexes are compounds of the formula (1), containing a moiety M(L)n of the formula (2) or formula (3).
    Type: Grant
    Filed: June 17, 2011
    Date of Patent: July 5, 2016
    Assignee: Merck Patent GmbH
    Inventors: Philipp Stoessel, Dominik Joosten, Anja Gerhard, Esther Breuning, Niels Schulte
  • Patent number: 9382244
    Abstract: The compound 4-(2-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl)-2,7-naphthyridin-1-ylamine and pharmaceutically usable salts and/or tautomers thereof. The use of this compound for the treatment of tumors, tumor growth, tumor metastases and/or AIDS.
    Type: Grant
    Filed: September 9, 2013
    Date of Patent: July 5, 2016
    Assignee: Merck Patent GmbH
    Inventors: Alfred Jonczyk, Frank T. Zenke, Christiane Amendt
  • Patent number: 9385337
    Abstract: The present invention relates inter alia to light- and/or irradiation-emitting fibers comprising nanocrystals, in particular quantum dots and nanorods, their preparation and use. The fiber may have a fiber core 10, an outer first electrode 20, a light emitting layer 30, a radiation transmissive second electrode 40 positioned over the organic light emitting layer 30. Eventually the fiber may also comprise an optional radiation transmissive moisture and/or air barrier layer 50 and/or an optional radiation transmissive encapsulating material 60.
    Type: Grant
    Filed: December 21, 2012
    Date of Patent: July 5, 2016
    Assignee: Merck Patent GmbH
    Inventor: Junyou Pan
  • Patent number: 9383621
    Abstract: This invention relates to electrophoretic fluids, the use of these fluids for the preparation of an electrophoretic display device, and electrophoretic displays comprising such fluids.
    Type: Grant
    Filed: November 13, 2012
    Date of Patent: July 5, 2016
    Assignee: Merck Patent GmbH
    Inventors: Ashley Nathan Smith, Mark John Goulding
  • Patent number: 9385335
    Abstract: The present invention relates to phosphorescent organic electroluminescent devices which have a low concentration of the phosphorescent emitter in the emitting layer.
    Type: Grant
    Filed: March 7, 2012
    Date of Patent: July 5, 2016
    Assignee: Merck Patent GmbH
    Inventors: Christof Pflumm, Niels Schulte
  • Patent number: 9382224
    Abstract: The present invention relates to chromen-4-one derivatives of the formula (I), to the use thereof as self-tanning substance or for increasing melanin synthesis, improving melanin transport and/or improving the distribution of melanin in suprabasal layers, and to preparations comprising these chromen-4-one derivatives.
    Type: Grant
    Filed: December 27, 2011
    Date of Patent: July 5, 2016
    Assignee: MERCK PATENT GMBH
    Inventors: Christophe Carola, Rene Peter Scheurich
  • Publication number: 20160186056
    Abstract: The present invention relates to europium-doped phosphors, to a process for the preparation thereof, and to the use of these compounds as conversion phosphors. The present invention furthermore relates to light-emitting devices which comprise the phosphor according to the invention.
    Type: Application
    Filed: July 9, 2014
    Publication date: June 30, 2016
    Applicant: MERCK PATENT GMBH
    Inventors: Holger WINKLER, Thomas JUESTEL, Arturas KATELNIKOVAS, Tobias DIERKES
  • Publication number: 20160185972
    Abstract: The present invention relates to interference pigments based on multicoated flake-form substrates which have on the surface of the substrate a layer sequence comprising (A0) optionally a high-refractive-index coating consisting of a layer of TiO2, (A) a high-refractive-index coating consisting of a mixture of TiO2 and Fe2O3, which may optionally be doped with one or more further oxides, (B) a high-refractive-index layer consisting of SnO2, (C) a high-refractive-index coating which absorbs in the visible wavelength region, and optionally (D) an outer protective layer, and to the use thereof, in particular in paints, coatings, industrial coatings, automobile paints, automotive refinish paints, coil coating, powder coatings, printing inks, plastics, pigment pastes, pigment preparations and in dry preparations, such as, for example, granules.
    Type: Application
    Filed: December 9, 2013
    Publication date: June 30, 2016
    Applicant: Merck Patent GmbH
    Inventor: Christoph SCHMIDT
  • Publication number: 20160185519
    Abstract: A high pressure extraction capsule (1) for single beverage preparation has a porous hydrophobic membrane (5, 10) that acts as a barrier to fluid flow up to a certain pressure and exceeding said pressure allows for extracting the fluid with active ingredients but still acts as a barrier to particles, particularly ground herbs or roots, wherein the pore size of the membrane (5, 10) is bigger than 0.45 ?m and wherein the hydrophobic membrane (5, 10) is arranged to have a surface tension of less than 40 dynes/cm. The capsule (1) comprises an inlet port (2), a compartment (3) for holding a substance with active ingredients like, e.g. ground herbs or roots, an outlet port (4) and a hydrophobic membrane (5, 10) that separates the compartment (3) from the outlet port (4).
    Type: Application
    Filed: July 30, 2014
    Publication date: June 30, 2016
    Applicant: MERCK PATENT GMBH
    Inventors: Onur KAS, Sabine HARTWIG, Luc VAN DER HEYDEN, Guillaume DUMOND FILLON, Bettina FRANK, Gerhard JONSCHKER
  • Publication number: 20160184310
    Abstract: Compounds of the formula I in which R1-R3 and Z have the meanings indicated in Claim 1, are inhibitors of Tankyrase, and can be employed, inter alia, for the treatment of diseases such as cancer, cardiovascular diseases, central nervous system injury and different forms of inflammation.
    Type: Application
    Filed: July 10, 2014
    Publication date: June 30, 2016
    Applicant: MERCK PATENT GMBH
    Inventors: Dieter DORSCH, Hans-Peter BUCHSTALLER
  • Publication number: 20160184285
    Abstract: Compounds of the formula I in which R1-R3 have the meanings indicated in Claim 1, are inhibitors of Tankyrase, and can be employed, inter alia, for the treatment of diseases such as cancer, cardiovascular diseases, central nervous system injury and different forms of inflammation.
    Type: Application
    Filed: July 9, 2014
    Publication date: June 30, 2016
    Applicant: MERCK PATENT GMBH
    Inventors: Hans-Peter BUCHSTALLER, Dieter DORSCH
  • Patent number: 9379326
    Abstract: The present invention refers to a method for selectively structuring of a polymer matrix comprising AgNW (silver nano wires) or CNTs (carbon nano tubes) or comprising mixtures of AgNW and CNTs on a flexible plastic substructure or solid glass sheet. The method also includes a suitable etching composition, which allows to proceed the method in a mass production.
    Type: Grant
    Filed: September 28, 2012
    Date of Patent: June 28, 2016
    Assignee: MERCK PATENT GMBH
    Inventors: Werner Stockum, Oliver Doll, Ingo Koehler, Christian Matuschek
  • Patent number: 9379323
    Abstract: The present invention relates to novel compositions comprising light emitting materials and/or charge transporting materials and one or more organic solvents having a viscosity at 25° C. of at least 10 mPas and a boiling point of at most 400° C., to their use as inks for the preparation of organic light emitting diode (OLED) devices, to methods for preparing OLED devices using the novel formulations, and to OLED devices prepared from such methods and formulations.
    Type: Grant
    Filed: April 5, 2011
    Date of Patent: June 28, 2016
    Assignee: Merck Patent GmbH
    Inventors: Mark James, Magda Goncalves-Miskiewicz, Philip Edward May, Ruth Effenberger, Edgar Kluge, Heinrich Becker
  • Patent number: 9379330
    Abstract: The present invention relates to an electronic device comprising anode, cathode and at least one organic layer which comprises a compound of the formula (I) to (IV). The invention furthermore encompasses the use of compounds of the formula (I) to (IV) in an electronic device and to a compound of the formula (Ic) to (IVc).
    Type: Grant
    Filed: May 30, 2011
    Date of Patent: June 28, 2016
    Assignee: Merck Patent GmbH
    Inventors: Philipp Stoessel, Arne Buesing, Dominik Joosten
  • Patent number: 9376433
    Abstract: Compounds of the formula I in which R1, X, Y and n have the meanings indicated in claim 1, are inhibitors of Tankyrase, and can be employed, inter alia, for the treatment of diseases such as cancer, cardiovascular diseases, central nervous system injury and different forms of inflammation.
    Type: Grant
    Filed: July 12, 2013
    Date of Patent: June 28, 2016
    Assignee: Merck Patent GmbH
    Inventors: Dieter Dorsch, Hans-Peter Buchstaller
  • Patent number: 9376622
    Abstract: The invention relates to compounds of the formula I and to a liquid-crystalline medium which comprises one or more compounds of the formula I, in which R1, X1, X, Y1 and Y2 have the meanings indicated in Claim 1, and to the use thereof for electro-optical purposes, in particular for shutter glasses, 3D applications, in TN, PS-TN, STN, TN-TFT, OCB, IPS, PS-IPS, FFS, PS-FFS and PS-VA-IPS displays.
    Type: Grant
    Filed: December 9, 2013
    Date of Patent: June 28, 2016
    Assignee: Merck Patent GmbH
    Inventors: Harald Hirschmann, Andreas Pohle, Markus Czanta, Christian Schoenefeld, Elvira Montenegro, Volker Reiffenrath
  • Patent number: 9376426
    Abstract: Compounds of the formula (I) in which D, R1, R2, R3, R4 have the meanings indicated in Claim 1, are inhibitors of tyrosine kinases, in particular of Met kinase, and can be employed, inter alia, for the treatment of tumors.
    Type: Grant
    Filed: January 31, 2014
    Date of Patent: June 28, 2016
    Assignee: Merck Patent GmbH
    Inventors: Dieter Dorsch, Oliver Schadt, Frank Stieber, Andree Blaukat
  • Publication number: 20160181537
    Abstract: The present application relates to an electroluminescence device containing a) an anode, b) a cathode, c) at least one emitter layer containing at least one electroluminescent material and arranged between the anode and the cathode, and d) at least one electron transport layer containing at least one material having electron-conducting or predominantly electron-conducting properties and arranged between the at least one emitter layer and the cathode, said device being characterized in that the at least one emitter layer contains a polymer having hole-conducting or predominantly hole-conducting properties. The electroluminescence device according to the invention is distinguished by a high lifetime and a high radiation efficiency.
    Type: Application
    Filed: July 1, 2014
    Publication date: June 23, 2016
    Applicant: Merck Patent GmbH
    Inventors: Junyou Pan, Frank Egon Meyer